logo

For the Inventor, By the Inventor

Rehovot, Israel

Yeda Research and Development Co. Ltd

Calculating rank
USPTO Granted Patents = 29


Forward Citations = 0

Loading Chart...
Loading Chart...

113 inventors (with patents filed for the assignee):

goldMedal Asaph Aharoni (2 out of 13 patents)

silverMedal Jacob Klein (2 out of 15 patents)

bronzeMedal Ronit Goldberg (2 out of 15 patents)

4.  Noa Novershtern (2 out of 5 patents)

5.  Yoach Rais (2 out of 4 patents)

6.  Igor Lubomirsky (2 out of 17 patents)

7.  Valery Kaplan (2 out of 10 patents)

8.  Yonina Eldar (2 out of 3 patents)

9.  Yaqub Hanna (2 out of 2 patents)

10.  Ido Amit (1 out of 5 patents)

11.  Weifeng Lin (1 out of 7 patents)

12.  Eran Ophir (1 out of 8 patents)

13.  Yaki Eidelstein (1 out of 8 patents)

14.  Noga Or-Geva (1 out of 10 patents)

15.  Rotem Gidron Budovsky (1 out of 7 patents)


Core Competencies:
Quantum Computing Device
Ocular Discomfort Treatment
Laser-Based Contrast Control
Alzheimer's Disease
Rare Earth Metals Recovery
Liposomic Drug-Delivery
Stem Cell Culturing
Gene Expression Regulation
Non-Invasive Assay
Immunotherapy
Cardiomyocytes Proliferation
Super Resolution Ultrasound

29 patents:

1. 12760102 - ANTIBODIES SPECIFIC TO CTLA-4 AND USES THEREOF (2026-10-13),
2. 12758182 - Medical imaging with nonlinear waveform inversion (NLWI) system using recurrent neural network (2026-10-13),
3. 12751215 - Quantum computing device (2026-09-29),
4. 12740942 - Surface treatment of contact lens and treatment of ocular discomfort by water soluble polymers and lipids/liposomes (2026-09-22),
5. 12738449 - Laser-based contrast control in transmission electron microscopy (2026-09-15),
6. 12730080 - System and method for extraction of structural data of a sample from scan data (2026-09-08),
7. 12723064 - TREATING ALZHEIMER'S DISEASE (2026-09-01),
8. 12692612 - Recovery of rare earth metals from ferromagnetic alloys (2026-07-28),
9. 12692519 - ENGINEERED AUTOTROPHIC BACTERIA FOR CO2 CONVERSION TO ORGANIC MATERIALS (2026-07-28),
10. 12691390 - Enantio-specific crystallization system and method thereof (2026-07-28),
11. 12680083 - MEDIA FOR CULTURING NAIVE HUMAN PLURIPOTENT STEM CELLS (2026-07-14),
12. 12678601 - Ureteral stents and methods for using the same (2026-07-14),
13. 12673098 - METHODS AND COMPOSITIONS FOR TREATING CORONAVIRAL INFECTIONS (2026-07-07),
14. 12661353 - SPT5 INHIBITORS AND USES THEREOF (2026-06-23),
15. 12646764 - Method for recovering valuable metals from spent lithium-ion-batteries (2026-06-02),
Company Overview
Yeda Research and Development Co. Ltd, based in Rehovot, Israel, is a prominent technology transfer company affiliated with the Weizmann Institute of Science. It specializes in the commercialization of innovative research and technologies across various fields, including life sciences, biotechnology, and pharmaceuticals. Yeda plays a crucial role in bridging the gap between scientific discovery and market application, facilitating partnerships and licensing agreements to advance cutting-edge solutions that address global challenges.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

29 Patents

#17 in 7610002 Rehovot

#204 in Israel

#22,581 in the World

Rehovot, IL
Rehovot, Israel

Yeda Research and Development Co. Ltd

Forward Citations = 0

113 inventors:

goldMedal Asaph Aharoni (2 out of 13 patents)

silverMedal Jacob Klein (2 out of 15 patents)

bronzeMedal Ronit Goldberg (2 out of 15 patents)

4.  Noa Novershtern (2 out of 5 patents)

5.  Yoach Rais (2 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Yeda Research and Development Co. Ltd. Retrieved from https://idiyas.com/company/yeda-research-and-development-company

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…